Inhibition_NN
of_IN
T_NN
cell_NN
activation_NN
by_IN
the_DT
extracellular_JJ
matrix_NN
protein_NN
tenascin_NN
._.

Tenascin_NN
-LRB-_-LRB-
TN_NN
-RRB-_-RRB-
is_VBZ
an_DT
extracellular_JJ
matrix_NN
protein_NN
that_WDT
is_VBZ
expressed_VBN
widely_RB
in_IN
the_DT
fetus_NN
and_CC
sparingly_RB
in_IN
the_DT
adult_JJ
,_,
but_CC
reappears_VBZ
at_IN
high_JJ
levels_NNS
in_IN
certain_JJ
areas_NNS
of_IN
tissue_NN
insult_NN
such_JJ
as_IN
tumor_NN
matrices_NNS
and_CC
sites_NNS
of_IN
wound_NN
healing_NN
._.

We_PRP
show_VBP
here_RB
that_IN
soluble_JJ
TN_NN
inhibits_VBZ
proliferation_NN
of_IN
human_JJ
T_NN
cells_NNS
in_IN
response_NN
to_TO
alpha_NN
CD3_NN
Ab_NN
co-immobilized_VBN
with_IN
the_DT
extracellular_JJ
matrix_NN
protein_NN
fibronectin_NN
-LRB-_-LRB-
FN_NN
-RRB-_-RRB-
._.

TN_NN
also_RB
inhibits_VBZ
proliferation_NN
driven_VBN
by_IN
alpha_NN
CD3\/IL_NN
-2_CD
or_CC
by_IN
phorbol_NN
ester\/IL_NN
-2_CD
,_,
and_CC
it_PRP
prevents_VBZ
high_JJ
level_NN
induction_NN
of_IN
IL-2R_NN
._.

The_DT
presence_NN
of_IN
TN_NN
in_IN
culture_NN
medium_NN
does_VBZ
not_RB
detectably_RB
alter_VB
the_DT
pattern_NN
of_IN
tyrosine_NN
phosphorylation_NN
resulting_VBG
from_IN
T_NN
cell_NN
triggering_NN
with_IN
alpha_NN
CD3_NN
,_,
but_CC
at_IN
later_JJ
time_NN
points_NNS
prevents_VBZ
the_DT
appearance_NN
of_IN
functional_JJ
NF-AT1_NN
transcription_NN
factor_NN
complexes_NNS
in_IN
T_NN
cell_NN
nuclear_JJ
extracts_NNS
._.

These_DT
findings_NNS
are_VBP
consistent_JJ
with_IN
the_DT
postulated_VBN
role_NN
for_IN
TN_NN
as_IN
a_DT
natural_JJ
antagonist_NN
to_TO
FN_NN
action_NN
,_,
and_CC
suggest_VBP
that_IN
T_NN
cell_NN
responses_NNS
occurring_VBG
at_IN
tissue_NN
sites_NNS
in_IN
which_WDT
TN_NN
is_VBZ
expressed_VBN
could_MD
be_VB
influenced_VBN
by_IN
its_PRP$
presence_NN
._.

